IRWD IRONWOOD PHARMA CLASS A
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 7 analyst firms say about IRONWOOD PHARMA CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 7 analyst/firm records · 7 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 2 reports on IRWD from 2 analyst firms in the last 90 days (7 firms in the past year).
Comparing each firm's latest target with its previous one: 1 has its first observed target in the past year.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Citigroup | Unnamed analyst | Buy | 5 Jan 2026 | — |
| Citizens JMP | Jason Butler | Buy | 26 Feb 2026 | 10.00 USD |
| Craig-Hallum | Chase Knickerbocker | Buy | 16 Jul 2026 | 5.70 USD |
| Jefferies | Akash Tewari | Hold | 25 Sep 2026 | 3.70 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | Mohit Bansal | Hold | 1 Jun 2026 | 5.00 USD |
| Data feed RESEARCH | Research Team | Hold | 30 Jul 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:17 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.